Inter-relationships between proprotein convertase subtilisin/kexin type 9, apolipoprotein C-III and plasma apolipoprotein B-48 transport in obese subjects: a stable isotope study in the postprandial state

Proprotein Convertase Subtilisin Kexin Type 9 Promotes Intestinal Overproduction of Triglyceride-Rich Apolipoprotein B Lipoproteins Through Both Low-Density Lipoprotein Receptor–Dependent and –Independent Mechanisms

(2014) Shirya Rashid et al.   CIRCULATION

PCSK9

(2014) Nabil G. Seidah et al.   CIRCULATION RESEARCH

Risk prediction with proprotein convertase subtilisin/kexin type 9 (PCSK9) in patients with stable coronary disease on statin treatment

(2014) Christian Werner et al.   VASCULAR PHARMACOLOGY

Transintestinal Cholesterol Excretion Is an Active Metabolic Process Modulated by PCSK9 and Statin Involving ABCB1

(2013) Cédric Le May et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Plasma Apolipoprotein B-48 Transport in Obese Men: A New Tracer Kinetic Study in the Postprandial State

(2013) Annette T. Y. Wong et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Can Mediate Degradation of the Low Density Lipoprotein Receptor-Related Protein 1 (LRP-1)

(2013) Maryssa Canuel et al.   PLoS One

Regulation of chylomicron production in humans

(2011) Changting Xiao et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Lack of a relationship between plasma PCSK9 concentrations and hepatic lipoprotein kinetics in obese people

(2011) Shelby Sullivan et al.   Translational Research

Proprotein Convertase Subtilisin Kexin Type 9 Null Mice Are Protected From Postprandial Triglyceridemia

(2009) Cédric Le May et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Plasma Proprotein Convertase Subtilisin/Kexin Type 9: A Marker of LDL Apolipoprotein B-100 Catabolism?

(2009) D. C. Chan et al.   CLINICAL CHEMISTRY

Intestinal lipoprotein overproduction in insulin-resistant states

(2008) Khosrow Adeli et al.   CURRENT OPINION IN LIPIDOLOGY

An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?

(2008) D. C. Chan et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE